Search Results for: results

By Kuldip K. Ambastha On Friday, February 24, 2023, the stock price of Autodesk, Inc. (ADSK), a software corporation, fell by -12.9% per share. While Autodesk’s latest quarterly results were relatively strong, its future guidance on earnings and free cash flow worried Wall Street. Autodesk is moving from offering multi-year contracts (with cash all paid …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 21-24, 2023”

By Kuldip K. Ambastha On the trading day of February 9, 2023, the stock price of Credit Suisse Group AG (CS), a Swiss financial institution, fell by -15.6% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of October 24-28, 2022; By Kuldip K. Ambastha.”) Credit Suisse’s …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 6-10, 2023”

By Kuldip K. Ambastha The stock price of Innovative Industrial Properties, Inc. (IIPR), an American real estate investment trust (REIT) focused on specialized properties rented out to state-licensed cannabis facilities through sale-leaseback agreements, fell by -16.9% per share on the trading day of Thursday, January 19, 2023. Investors were disappointed in the results disclosed by …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 17-20, 2023”

By Kuldip K. Ambastha On Thursday, January 5, 2023, the stock of NovoCure Limited (NVCR), an oncology company, rose by +68.5% for the trading day. The LUNAR study has shown that a medical device developed by NovoCure is able to improve, in a statistically significant way, the prospect of survival for people with late-stage lung …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 3-6, 2023”

By Kuldip K. Ambastha The stock price of Zscaler, Inc. (ZS), a cloud security company, dropped by -10.7% per share on the trading day of Friday, December 2, 2022. In its latest quarterly results, Zscaler surpassed expectations when it came to earnings and revenues. However, the expected billings figure for the full year is lower …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 28-December 2, 2022”

By Kuldip K. Ambastha On Thursday, November 17, 2022, the stock price of Bath & Body Works, Inc. (BBWI), a prominent specialty retail company, rose by +25.2% per share. This rise in the stock price was driven by strong 3Q2022 quarterly performance results, with earnings surpassing the expected consensus estimate. Furthermore, Bath & Body Works, …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 14-18, 2022”

By Kuldip K. Ambastha YETI Holdings, Inc. (YETI), an outdoor products company, had its stock price shoot up by +31.6% per share on Thursday, November 10, 2022, followed by another +10.0% per share on Friday, November 11, 2022. The company announced strong performance results in 3Q2022, and this information drove the increase in the stock …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 7-11, 2022”

By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 10-14, 2022”

By Kuldip K. Ambastha On Thursday, September 29, 2022, the stock price of CarMax, Inc. (KMX), a used vehicle retailer, dropped by -24.6% per share. The American company’s latest quarterly performance results disappointed Wall Street, especially from the perspective of earnings per share (EPS). The current landscape of high inflation, higher interest rates (making for …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 26-30, 2022”

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 6-9, 2022”